Search results for "poros"

showing 10 items of 1076 documents

A Prospective Open-Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tableton Upper Gastrointestinal Safety and Medicati…

2021

Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeuticoption for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability is warranted. Inthis multicenter prospective, observational, postauthorization safety study conducted in Italy and Spain, postmenopausal women(PMW) with osteoporosis (naïve to bisphosphonates) were treated weekly with a buffered soluble alendronate 70 mg effervescent(ALN-EFF) tablet (Binosto®) and followed for 12  3 months. Information was collected on adverse events (AEs), medication errors,persistence, and compliance using the Morisky-Green questionnai…

GASTROINTESTINAL ADVERSE EVENTSPOSTMENOPAUSAL WOMENEFFERVESCENTOSTEOPOROSISALENDRONATE
researchProduct

A Prospective Open‐Label Observational Study of a Buffered Soluble 70 mg Alendronate Effervescent Tablet on Upper Gastrointestinal Safety and Medicat…

2021

Upper gastrointestinal (GI) side effects are a main reason for discontinuing bisphosphonate treatment, an important therapeutic option for osteoporosis patients. Consequently, the development of novel formulations with improved tolerability is warranted. In this multicenter prospective, observational, postauthorization safety study conducted in Italy and Spain, postmenopausal women (PMW) with osteoporosis (naïve to bisphosphonates) were treated weekly with a buffered soluble alendronate 70 mg effervescent (ALN-EFF) tablet (Binosto®) and followed for 12 ± 3 months. Information was collected on adverse events (AEs), medication errors, persistence, and compliance using the Morisky-Green questi…

GASTROINTESTINAL ADVERSE EVENTSmedicine.medical_specialtyAgingNauseaEndocrinology Diabetes and MetabolismOsteoporosisDiseases of the musculoskeletal systemOSTEOPOROSISInternal medicineparasitic diseasesmedicineClinical endpointOrthopedics and Sports MedicineCumulative incidenceAdverse effectALENDRONATEOrthopedic surgerybusiness.industryalendronate; effervescent; gastrointestinal adverse events; osteoporosis; postmenopausal womenEvaluation of treatments and therapeutic interventionsEFFERVESCENTOriginal Articlesmedicine.diseaseConfidence intervalDiscontinuationTolerabilityPOSTMENOPAUSAL WOMENRC925-9356.1 PharmaceuticalsOsteoporosisOriginal ArticlePatient Safetymedicine.symptombusinessDigestive DiseasesRD701-811JBMR Plus
researchProduct

Dynamics of myoglobin in confinement: An elastic and quasi-elastic neutron scattering study

2008

In order to clarify the role of hard confinement on protein dynamics, elastic and quasi-elastic neutron scattering experiments have been performed on ferric horse myoglobin in two different systems: the protein embedded in a porous silica matrix, and the corresponding hydrated protein powder. Elastic data have been analysed using two different models (dynamical heterogeneity and anharmonic double-well potential) that take into account deviations of elastic intensity from Gaussian behaviour. The profile of quasi-elastic spectra has been approximated by a combination of Lorentzian and Gaussian components. Comparison between the data relative to the two different samples indicates that geometr…

GLASS-TRANSITIONGaussianGeneral Physics and AstronomyHydrationNeutron scatteringSol–gelMYELIN BASIC-PROTEINMolecular physicsSpectral linesymbols.namesakechemistry.chemical_compoundDynamical heterogeneityPhysical and Theoretical ChemistryPorosityHEMOGLOBINSOLVENTQuantitative Biology::BiomoleculesProtein dynamicsAnharmonicitySolvent dynamicCrystallographyMyoglobinchemistrysymbolsProtein dynamicSilica hydrogels
researchProduct

Gastrointestinal symptoms and association with medication use patterns, adherence, treatment satisfaction, quality of life, and resource use in osteo…

2016

The Medication Use Patterns, Treatment Satisfaction, and Inadequate Control of Osteoporosis Study (MUSIC-OS) is a prospective, observational study of women with osteoporosis in Europe and Canada. At baseline, patients with gastrointestinal symptoms reported lower adherence to osteoporosis treatment, treatment satisfaction, and health-related quality of life, than those without gastrointestinal symptoms. INTRODUCTION: The aim of the study was to examine gastrointestinal (GI) symptoms and the association between GI symptoms and treatment adherence, treatment satisfaction, and health-related quality of life (HRQoL) among osteoporotic women in Europe and Canada. METHODS: Baseline results are re…

Gastrointestinal DiseasesEndocrinology Diabetes and MetabolismHealth-related quality of lifeOsteoporosisFRACTURE RISKRISEDRONATE0302 clinical medicineEndocrinologyQuality of lifeBack pain030212 general & internal medicineProspective StudiesHEALTH PLANProspective cohort studyALENDRONATEOsteoporosis PostmenopausalPOPULATIONeducation.field_of_studyBone Density Conservation AgentsDiphosphonatesBISPHOSPHONATE THERAPYSettore MED/34 - Medicina Fisica E RiabilitativaTRACT SAFETYBisphosphonatesMiddle AgedEuropeDiabetes and MetabolismPOSTMENOPAUSAL WOMENPatient SatisfactionHealth ResourcesFemaleOriginal ArticlePostmenopausalmedicine.symptomBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Aged; Bone Density Conservation Agents; Canada; Diphosphonates; Europe; Female; Gastrointestinal Diseases; Health Resources; Humans; Medication Adherence; Middle Aged; Osteoporosis Postmenopausal; Patient Satisfaction; Prospective Studies; Psychometrics; Quality of Life; Endocrinology Diabetes and Metabolismmedicine.medical_specialtyCanadaGastrointestinalPsychometricsPopulation030209 endocrinology & metabolismNOMedication Adherence03 medical and health sciencesInternal medicinemedicineHumanseducationBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Aged; Bone Density Conservation Agents; Canada; Diphosphonates; Europe; Female; Gastrointestinal Diseases; Health Resources; Humans; Medication Adherence; Middle Aged; Osteoporosis Postmenopausal; Patient Satisfaction; Prospective Studies; Psychometrics; Quality of LifeAgedTreatment satisfactionbusiness.industryPERSISTENCEbisphosphonates gastrointestyinal osteoporosis postmenopausal treatment satisfactionBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfactionmedicine.diseaseRheumatologyCLINICAL-PRACTICEOrthopedic surgeryQuality of LifeOsteoporosisObservational studybusinessBisphosphonates; Gastrointestinal; Health-related quality of life; Osteoporosis; Postmenopausal; Treatment satisfaction; Endocrinology Diabetes and Metabolism
researchProduct

Modelling wet-air oxidation of phenol in a trickle-bed reactor using active carbon as a catalyst

2014

BACKGROUND Catalytic wet air oxidation (CWAO) of phenol in a trickle-bed reactor has been investigated (operating parameters: P=1.85 MPa, T=393, 413, 433 K, L=0.17–1.77 kg m−2 s−1 and G=0.2–0.62 kg m−2 s−1). Activated carbon was used as a catalyst. The experimental results have been simulated by Eulerian multifluid model (CFD) and for comparison by the plug flow model. RESULTS The experiments proved that active carbon can be applied as a catalyst in the phenol oxidation processes revealing a catalytic activity comparable with that of commonly used metal oxides. The highest conversion of phenol obtained in long-lasting experimental runs carried out at stable catalytic activity (PO2 = 0.31 MP…

General Chemical Engineering02 engineering and technologyCatalysisInorganic ChemistryMetalchemistry.chemical_compound020401 chemical engineeringmedicinePhenolWet oxidation0204 chemical engineeringPorosityWaste Management and DisposalChromatographyPlug flowRenewable Energy Sustainability and the EnvironmentChemistryOrganic ChemistryTrickle-bed reactor021001 nanoscience & nanotechnologyPollutionFuel TechnologyChemical engineeringvisual_artvisual_art.visual_art_medium0210 nano-technologyBiotechnologyActivated carbonmedicine.drugJournal of Chemical Technology & Biotechnology
researchProduct

A prospect for computing in porous materials research: Very large fluid flow simulations

2016

Abstract Properties of porous materials, abundant both in nature and industry, have broad influences on societies via, e.g. oil recovery, erosion, and propagation of pollutants. The internal structure of many porous materials involves multiple scales which hinders research on the relation between structure and transport properties: typically laboratory experiments cannot distinguish contributions from individual scales while computer simulations cannot capture multiple scales due to limited capabilities. Thus the question arises how large domain sizes can in fact be simulated with modern computers. This question is here addressed using a realistic test case; it is demonstrated that current …

General Computer ScienceComputer scienceLattice Boltzmann method0208 environmental biotechnologyGPULattice Boltzmann methods02 engineering and technologyParallel computing01 natural sciencesPermeability010305 fluids & plasmasTheoretical Computer ScienceComputational sciencePorous materialPetascale computing0103 physical sciencesFluid dynamicsFluid flow simulationPorosityta113ta114Supercomputer020801 environmental engineeringAddressing modePermeability (earth sciences)Petascale computingModeling and SimulationPorous mediumJournal of Computational Science
researchProduct

Calcium binding and ionic conduction in single conical nanopores with polyacid chains: model and experiments.

2012

Calcium binding to fixed charge groups confined over nanoscale regions is relevant to ion equilibrium and transport in the ionic channels of the cell membranes and artificial nanopores. We present an experimental and theoretical description of the dissociation equilibrium and transport in a single conical nanopore functionalized with pH-sensitive carboxylic acid groups and phosphonic acid chains. Different phenomena are simultaneously present in this basic problem of physical and biophysical chemistry: (i) the divalent nature of the phosphonic acid groups fixed to the pore walls and the influence of the pH and calcium on the reversible dissociation equilibrium of these groups; (ii) the asym…

General Physics and AstronomyIonic bondingFunctionalizedDissociation (chemistry)Conical nanoporeNanoscale regionschemistry.chemical_compoundNanoporesI - V curveIonic conductivityGeneral Materials ScienceConical nanoporesPhosphonate groupCalcium concentrationChemistryGeneral EngineeringPH effectsPartition functionsIonic channelsIon equilibriumReversible dissociationChemical physicsFunctional groupsThermodynamicsDesalination membranesIon bindingPorosityDissociationBiophysical chemistryDissociation equilibriaInorganic chemistrychemistry.chemical_elementWater filtrationCalciumIonNernst-Planck equationsApplied potentialsIon bindingCarboxylationPhosphonic acidsComputer SimulationCarboxylateParticle SizeControlled drug releaseCurrent voltage curveIonsBinding SitesFixed charge densityPH sensitiveCarboxylic acidsDesalinationPhosphonic acid groupsPoly acidsElectric ConductivityCarboxylic acid groupsFixed ChargesNanostructuresCell membranesCurrent-voltage curvesModels ChemicalQuantum theoryFISICA APLICADACalciumBiological ion channelsCalcium bindingIonic currentCytologyPore wallStatistical mechanicsAcidsACS nano
researchProduct

Calcium in the prevention of postmenopausal osteoporosis: EMAS clinical guide

2017

Abstract Introduction Postmenopausal osteoporosis is a highly prevalent disease. Prevention through lifestyle measures includes an adequate calcium intake. Despite the guidance provided by scientific societies and governmental bodies worldwide, many issues remain unresolved. Aims To provide evidence regarding the impact of calcium intake on the prevention of postmenopausal osteoporosis and critically appraise current guidelines. Materials and methods Literature review and consensus of expert opinion. Results and conclusion The recommended daily intake of calcium varies between 700 and 1200 mg of elemental calcium, depending on the endorsing source. Although calcium can be derived either fro…

Genetics and Molecular Biology (all)OsteoporosisElemental calciumDiseaseDAIRY-PRODUCTSBiochemistrylaw.inventionCalcium; Diet; Excess-calcium risk; Postmenopausal osteoporosis; Prevention; Biochemistry Genetics and Molecular Biology (all); Obstetrics and GynecologyFractures Bone0302 clinical medicineRandomized controlled trial3123 Gynaecology and paediatricslawVITAMIN-D SUPPLEMENTATION030212 general & internal medicineVitamin DOsteoporosis PostmenopausalDIETARY CALCIUMObstetrics and GynecologyVitaminsRANDOMIZED CONTROLLED-TRIAL3. Good healthCARDIOVASCULAR-DISEASEDietary Reference IntakeFemalemedicine.medical_specialtychemistry.chemical_element030209 endocrinology & metabolismCalciumReference Daily IntakeGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciencesPostmenopausal osteoporosisInternal medicinemedicineVitamin D and neurologyHumansCORONARY-HEART-DISEASESYMPTOMATIC KIDNEY-STONESIntensive care medicinebusiness.industryPreventionSERUM-CALCIUMUPDATED METAANALYSISmedicine.diseaseFRACTURE PREVENTIONDietCalcium DietaryExcess-calcium riskEndocrinologychemistryDietary SupplementsOsteoporosisCalciumbusinessMaturitas
researchProduct

The dental management of patients at risk of medication-related osteonecrosis of the jaw: New paradigm of primary prevention

2018

Medication-related osteonecrosis of the jaw (MRONJ) is a serious adverse reaction of antiresorptive and antiangiogenic agents; it is a potentially painful and debilitating condition that can considerably affect the quality of life of patients. Furthermore, even if its epidemiology and pathogenesis have still not been fully clarified, several risk factors related to MRONJ have been recognized in prevention protocols. Three main risk factors are as follows: (i) the type of ONJ-related medications: antiresorptive (e.g., Bisphosphonates, Denosumab) and antiangiogenic drugs (e.g., Bevacizumab, Sunitinib); (ii) the category of patient at MRONJ risk: cancer versus non-cancer patient; (iii) the typ…

Genetics and Molecular Biology (all)medicine.medical_specialtyBevacizumabImmunology and Microbiology (all)lcsh:MedicineAngiogenesis InhibitorsReview ArticleBiochemistryGeneral Biochemistry Genetics and Molecular Biology03 medical and health sciences0302 clinical medicineQuality of lifeSettore MED/28 - Malattie OdontostomatologicheNeoplasmsOral and maxillofacial pathologyEpidemiologymedicineHumansIntensive care medicineAdverse effectBiochemistry Genetics and Molecular Biology (all)Bone Density Conservation AgentsDiphosphonatesGeneral Immunology and MicrobiologySunitinibbusiness.industrylcsh:R030206 dentistryGeneral Medicinemedicine.diseaseDenosumab030220 oncology & carcinogenesisOsteoporosisBisphosphonate-Associated Osteonecrosis of the JawbusinessOsteonecrosis of the jawBiochemistry Genetics and Molecular Biology (all); Immunology and Microbiology (all)medicine.drug
researchProduct

Isoflavonoid-based bone-sparing treatments exert a low activity on reproductive organs and on hepatic metabolism of estradiol in ovariectomized rats

2007

International audience; The use of soy isoflavones is a potential alternative to hormone replacement therapy in post-menopausal bone-loss prevention. Nevertheless, phytoestrogens can target other organs and may disrupt cell proliferation, or could modify endogenous steroid hormone metabolism. These mechanisms could be linked to an increased risk of developing cancer. We therefore studied the possible side effects of such treatments in an experimental model of menopause. Forty adult female Wistar rats were ovariectomized and fed with a genistein-, daidzein- or equol-supplemented diet at bone-sparing levels (10 mg/kg BW/day) for 3 months. The estrogenic effects were assessed by histological a…

GenisteinEstrogen receptorToxicologychemistry.chemical_compound0302 clinical medicineCytochrome P-450 Enzyme SystemBone Density[SDV.IDA]Life Sciences [q-bio]/Food engineeringESTROGEN RECEPTORS0303 health sciencesEstradiolfood and beveragesOrgan SizeEquolGenistein3. Good healthCYTOCHROME P450SOY ISOFLAVONEHormone receptor030220 oncology & carcinogenesisVaginaMicrosomes LiverFemaleMenopauseEQUOLmedicine.medical_specialtymedicine.drug_classOvariectomyPhytoestrogensBiology03 medical and health sciencesProliferating Cell Nuclear AntigenInternal medicinemedicineUTEROTROPHYAnimals[SPI.GPROC]Engineering Sciences [physics]/Chemical and Process EngineeringRats Wistar030304 developmental biologyPharmacologyUterusDaidzeinIsoflavonesRatsDisease Models AnimalEndocrinologyGene Expression RegulationchemistryEstrogenESTRADIOL METABOLISMOsteoporosisPhytoestrogensSteroid hormone metabolism
researchProduct